The Horizons Program provides carefully structured access to experimental cellular therapies while generating meaningful clinical data to support regulatory advancement.
The Horizons Program provides carefully structured access to experimental cellular therapies while generating meaningful clinical data to support regulatory advancement.
A clinical research access platform — not medical tourism.
We combine structured treatment with rigorous data collection, in collaboration with U.S.-based physicians, to address diseases that lack effective therapies. We provide access to experimental cellular therapies at very low cost. In return, patients participate in carefully designed data collection before and after therapy — generating evidence to bring these therapies into regulated U.S. pathways under FDA authorization.
Focused on autoimmune and inflammatory diseases
Conditions listed do not represent approved indications. Participation depends on eligibility and physician review.
For rheumatologists, neurologists, gastroenterologists, and other specialists treating autoimmune and inflammatory conditions.
The Horizons Program works in close collaboration with U.S.-based physicians. Your involvement helps ensure patient safety, continuity of care, and the collection of high-quality clinical data.
Provide baseline evaluation in patients considering participating in this program.
Order labs and imaging that inform treatment decisions and serve as baseline measures.
Complete follow-up assessments that are typically part of standard care, contributing to meaningful data collection.
Patients or their physicians reach out to the Horizons Program team to express interest and begin the process.
The Horizons team reviews the patient's medical history, diagnosis, and prior treatments to assess eligibility.
Collaboration with the patient's current specialty provider for baseline evaluation, labs, and imaging.
The patient travels to the clinical site for experimental cellular therapy administered under appropriate licensure and regulatory authority.
Structured follow-up assessments are conducted to track outcomes and collect meaningful clinical data.
A confirmed diagnosis of an autoimmune or inflammatory condition.
Persistent symptoms despite standard therapy.
Ability to travel to the clinical site for treatment.
Have a collaborating physician who can participate in baseline and follow-up evaluations.
Willing to participate in structured data collection at each follow-up interval.
Think you may be eligible?
Start Your Application
The Horizons Program is built on a foundation of scientific rigor. Every patient interaction is an opportunity to generate data that supports the broader goal of FDA regulatory advancement.
We collect standardized, validated clinical outcome measures across all treated patients, ensuring data quality and comparability.
Patients complete validated scales specific to their disease as well as general quality-of-life instruments at each follow-up.
All data is collected in an FDA-compliant database. The program aggregates this data to build the evidence base needed for future FDA submission and regulatory pathways.
Unlike traditional medical tourism, the Horizons Program is built on transparency, scientific credibility, and patient-centered values.
We provide access to experimental cellular therapies at very low cost. In return, participants contribute valuable clinical data that helps advance regulatory approval. Charitable donations help offset travel, lodging, and essential program costs for patients who otherwise could not participate.
Contact Us About Donating